(600332)"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Receipt of Drug Registration Certificate by Subsidiary
Filed with SSE · Stock code 600332 · · 3 pages · Chinese
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Story so far
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Changes to Matters Concerning the Equity Investment Fund and Progress of the Related Party Transaction
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Receipt of the Drug Registration Certificate in Macao by Guangzhou Baiyunshan Bioproducts Co., Ltd.
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Convening the 2026 Semi-annual Performance Briefing
Earlier from Guangzhou Baiyunshan Pharmaceutical
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Indicative Announcement on Change in Equity Structure of Controlling Shareholder
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Changes to Matters Concerning the Equity Investment Fund and Progress of the Related Party Transaction
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Receipt of the Drug Registration Certificate in Macao by Guangzhou Baiyunshan Bioproducts Co., Ltd.
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Convening the 2026 Semi-annual Performance Briefing
- "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Implementation of Dividend Distribution for the First Half of 2026
Later from Guangzhou Baiyunshan Pharmaceutical
All Guangzhou Baiyunshan Pharmaceutical news releasesFollow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical